UT Southwestern researchers showed how mutations in DNA packaging machines cause cancer
On Sept. 7, 2020, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI) determined how…
-
-
DiaSorin Molecular received FDA clearance for the Simplexa Flu A/B & RSV Direct Gen II Assay
On Sept. 7, 2020, DiaSorin Molecular announced that it had received U.S. Food and Drug Administration (FDA) Clearance…
-
BioNTech and Pfizer receive regulatory approval to commence global phase 2/3 trial for COVID-19 vaccine candidate
On Sept. 7, 2020, Pfizer and BioNTech announced that the German regulatory authority, the Paul-Ehrlich-Institut, had approved the…
-
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers found that natural infection with COVID-19 produces a robust…
-
Sanofi and GSK initiated Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
On Sept. 3, 2020, Sanofi and GSK announced the start of the Phase 1/2 clinical trial for their…
-
Biotechnology | CDC | Infectious Disease | Influenza | NIH | Therapeutics
U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National Stockpile
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
-
U.S. Department of Defense sites selected for phase III COVID-19 vaccine trials
On Sept. 3, 2020, the U.S Department of Defense announced that five locations were identified to participate in…
-
RedHill Biopharma’s Opaganib awarded COVID-19 grant by State of Pennsylvania
On Sept. 3, 2020, RedHill Biopharma announced the selection of opaganib, a proprietary, first-in-class, orally-administered, sphingosine kinase-2 (SK2)…
-
Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
-
Johnson & Johnson announced COVID-19 investigational vaccine candidate prevents severe clinical disease in hamsters
On Sept. 3, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
-
BioMedomics’ Sickle SCANﾮ approved by Department of Health in Australia
On Sept. 3, 2020, BioMedomics announced that the Therapeutic Goods Administration, a branch of the Department of Health…
-
ADMA Biologics launched COVID-19 ImmunoRank Neutralization MICRO-ELISA for detection of SARS-CoV-2
On Sept. 3, 2020, ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA…
-
Roche received FDA Emergency Use Authorization for the cobas SARS-CoV-2 & influenza A/B test for use on cobas 6800/8800 systems
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
-
Custom face shields aimed to block droplets, tackled COVID-19 for football players
On Sept. 3, 2020, researchers from the Virginia Tech Helmet Lab announced the development of a football helmet…
-
Biotechnology | COVID-19 | FDA
OraSure’s ORAcollect-RNA device Included in EUA granted to MiraDx for SARS-CoV-2 test
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ﾷRNA (OR-100) collection device was included along with other…
-
COVID-19 vaccine study shows severe disease preventable in hamsters
On Sept. 3, 2020, Oregon Health & Science University (OHSU) announced that for the first time, early research…
-
Virginia Tech researchers began testing campus wastewater for COVID-19
On Sept. 3, 2020, a team of Virginia Tech researchers announced that they will begin testing wastewater at…
-
Broad Institute provided COVID-19 screening for students, faculty and staff at more than 100 colleges and universities
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
-
Janssen discontinued Pimodivir influenza development program
On Sept. 2, 2020, the Janssen Pharmaceutical Companies of Johnson & Johnson announced that it had made a…
-
Aegis Sciences awarded $66 million NIH grant to rapidly expand COVID-19 test capacity
On Sept. 2, 2020, Aegis Sciences announced that it had been selected to participate in the National Institutes…
-
OPKO Health’s BioReference Laboratories announced New York City Schools COVID-19 testing program
On Sept. 2, 2020, BioReference Laboratories, an OPKO Health company, began testing New York City principals, teachers and…
-
Novavax announced publication of phase 1 data for COVID-19 vaccine candidate in The New England Journal of Medicine
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
-
NIH to boost national COVID-19 testing capacity
On Sept. 2, 2020, the National Institutes of Health (NIH) announced $129.3 million in scale-up and manufacturing support…
-
US Army uniquely poised to battle global pandemic
On Sept. 2, 2020, U.S. Army Medical Research and Development Command continues to combat the virus on several…
-
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On Sept. 2, 2020, Mesoblast announced that it had received ethics approval to include Australian hospitals in the…
-
Biotechnology | Diagnostics | HIV | Infectious Disease | Non-Profit Research | Organ Transplant | Therapeutics
UT Southwestern performed first HIV-positive-to-HIV-positive organ transplant in Texas
On Sept. 2, 2020, less than three weeks after getting on an organ transplant list for HIV-positive patients,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | IRB | NIH
Sonic Healthcare expand COVID-19 testing capacity in US in collaboration with NIH RADx Initiative
On Sept. 2, 2020, Sonic Healthcare USA was awarded a contract from the National Institutes of Health (NIH)…
-
NIH awarded MicroGEM $409 million to fast-track rapid, no-lab COVID-19 saliva test
On Sept. 2, 2020, MicroGEM announced it had been awarded up to $40.9 million by the National Institutes…
-
PathGroup selected by NIH to become RADx program ‘mega-lab’ for COVID-19 testing
On Sept. 2, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
-
Roche received FDA approval for first HIV-1/HIV-2 Qualitative test on the cobas 6800/8800 Systems in the fight against HIV/AIDS
On Sept. 1, 2020, Roche announced FDA approval for the cobas HIV-1/HIV-2 Qualitative Test for use on the…
